4 |
PREMIUM INSIGHTS................................................................................................................. 32 |
|||
• 4.1 |
GLOBAL HUMAN INSULIN MARKET( 2015 – 2020).......................................................................................................... 32 |
|||
• 4.2 |
GLOBAL HUMAN INSULIN DRUGS MARKET SIZE, BY TYPE( 2015)............................................................................... 33 |
|||
• 4.3 |
GLOBAL HUMAN INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE( 2015-2020).................................................. 34 |
|||
• 4.4 |
GLOBAL HUMAN INSULIN DRUGS MARKET, BY BRAND( 2015 VS. 2020)..................................................................... 34 |
|||
• 4.5 |
GLOBAL HUMAN INSULIN PRODUCTS MARKET SIZE, BY COUNTRY( 2015-2020)....................................................... 35 |
|||
5 |
MARKET OVERVIEW.................................................................................................................. 36 |
|||
• 5.1 |
INTRODUCTION............................................................................................................................................................... 37 |
|||
• 5.2 |
MARKET SEGMENTATION................................................................................................................................................ 37 |
|||
• 5.3 |
MARKET EVOLUTION....................................................................................................................................................... 38 |
|||
• 5.4 |
MARKET DYNAMICS........................................................................................................................................................ 39 |
|||
• 5.4.1 |
KEY MARKET DRIVERS.................................................................................................................................. 40 |
|||
• 5.4.1.1 |
GROWTH IN THE NUMBER OF DIABETIC PATIENTS................................................................ 40 |
|||
• 5.4.1.2 |
RISING MARKET DEMAND FOR HUMAN INSULIN ANALOGS................................................. 41 |
|||
• 5.4.1.3 |
TECHNOLOGICAL ADVANCEMENTS IN HUMAN INSULIN DELIVERY DEVICES...................... 42 |
|||
• 5.4.1.4 |
FAVORABLE MEDICAL REIMBURSEMENT SCENARIO IN DEVELOPED COUNTRIES............... 43 |
|||
• 5.4.2 |
KEY MARKET RESTRAINTS............................................................................................................................ 43 |
|||
• 5.4.2.1 |
STRINGENT REGULATORY REQUIREMENTS FOR PRODUCT APPROVAL................................ 43 |
|||
• 5.4.3 |
KEY MARKET OPPORTUNITIES..................................................................................................................... 44 |
|||
• 5.4.3.1 |
EXPANSION OF HEALTHCARE INFRASTRUCTURE ACROSS EMERGING MARKETS............... 44 |
|||
• 5.4.3.2 |
EXPECTED PATENT EXPIRY OF KEY HUMAN INSULIN DRUGS............................................... 45 |
|||
• 5.4.4 |
KEY MARKET CHALLENGE............................................................................................................................ 45 |
|||
• 5.4.4.1 |
HIGH PRODUCT MANUFACTURING COSTS............................................................................ 45 |
|||